Articles related to Rexahn

Partnering spotlight: Robust pipeline at Rexahn led by three phase II drugs

March 9, 2009 - Conference: - Company: - Tags:

Reviewing the Rexahn Pharmaceuticals pipeline is like reading about a team of potential medal winning Olympic athletes. Each compound is an innovative or first in class product in its therapeutic segment. Three drugs are currently in Phase II clinical trials to treat cancers, central nervous system disorders, and sexual dysfunction. Further, IND filings for two Read more »

Newsletter

Subscribe to partneringNEWS
An online journal for executives in the life sciences, partneringNEWS™ is focused on the people behind the deals. Putting a human face to a collaboration agreement gives business development professionals the ability to get behind the headlines.

Sign up today to the free newsletter and never miss any new content.